0
26 September 2025
false
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2024-01-01
Sage Accounts Production Advanced 2023 - FRS102_2023
91,200
91,200
xbrli:pure
xbrli:shares
iso4217:GBP
10639796
2024-01-01
2024-12-31
10639796
2024-12-31
10639796
2023-12-31
10639796
2023-01-01
2023-12-31
10639796
2023-12-31
10639796
2022-12-31
10639796
core:DevelopmentCostsCapitalisedDevelopmentExpenditure
2024-01-01
2024-12-31
10639796
bus:Director4
2024-01-01
2024-12-31
10639796
core:DevelopmentCostsCapitalisedDevelopmentExpenditure
2024-12-31
10639796
core:WithinOneYear
2024-12-31
10639796
core:WithinOneYear
2023-12-31
10639796
core:ShareCapital
2024-12-31
10639796
core:ShareCapital
2023-12-31
10639796
core:RetainedEarningsAccumulatedLosses
2024-12-31
10639796
core:RetainedEarningsAccumulatedLosses
2023-12-31
10639796
bus:SmallEntities
2024-01-01
2024-12-31
10639796
bus:Audited
2024-01-01
2024-12-31
10639796
bus:SmallCompaniesRegimeForAccounts
2024-01-01
2024-12-31
10639796
bus:PrivateLimitedCompanyLtd
2024-01-01
2024-12-31
10639796
bus:FullAccounts
2024-01-01
2024-12-31
COMPANY REGISTRATION NUMBER:
10639796
|
Filleted Financial Statements |
|
|
Statement of Financial Position |
|
31 December 2024
Current assets
|
Debtors |
5 |
21,627 |
21,149 |
|
Cash at bank and in hand |
17,250 |
207 |
|
-------- |
-------- |
|
38,877 |
21,356 |
|
|
|
|
|
Creditors: amounts falling due within one year |
6 |
1,843,794 |
1,750,705 |
|
------------ |
------------ |
|
Net current liabilities |
1,804,917 |
1,729,349 |
|
------------ |
------------ |
|
Total assets less current liabilities |
(
1,804,917) |
(
1,729,349) |
|
------------ |
------------ |
|
Net liabilities |
(
1,804,917) |
(
1,729,349) |
|
------------ |
------------ |
|
|
|
|
Capital and reserves
|
Called up share capital |
60 |
60 |
|
Profit and loss account |
(
1,804,977) |
(
1,729,409) |
|
------------ |
------------ |
|
Shareholders deficit |
(
1,804,917) |
(
1,729,349) |
|
------------ |
------------ |
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the
board of directors
and authorised for issue on
18 September 2025
, and are signed on behalf of the board by:
Company registration number:
10639796
|
Notes to the Financial Statements |
|
Year ended 31 December 2024
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 208, Canalot Studios, 222 Kensal Road, London, W10 5BN, England.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
Having made appropriate enquiries and having reviewed the company's forecasts and projections, the directors are of the opinion that the company has adequate resources to continue in operational existence for the foreseeable future (at least 12 months from the date the accounts are approved and signed) and to meet its obligations and settle its liabilities as they fall due for payment. Accordingly, the financial statements are prepared on the going concern basis.
Revenue recognition
Turnover represents the amounts derived from the provision of goods and services, which fall within the company's ordinary activities, stated net of VAT. Competition or event revenue is recognised on the actual date the competition or event takes place. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably. When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period. When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
|
Website |
- |
33% straight line |
|
|
|
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
The Company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues of FRS 102 to all of its financial instruments. Financial instruments are recognised when the Company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the financial asset is measured at the present value of the future receipts discounted at a market rate of interest. Impairment of financial assets Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date. Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss. Derecognition of financial assets Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the Company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow Company companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost. using the effective interest rate method. Financial liabilities held at fair value Debt instruments where the contractual returns, repayment of the principal, or other terms (such as prepayment provisions or term extensions) do not meet the conditions to be measured at amortised cost, are subsequently measured at fair value through profit or loss, unless fair value measurement is not permitted by law, or the debt instrument gives rise to cash flows on specified dates that constitute repayment of the principal advanced, together with reasonable compensation for the time value of money, credit risk and other basic lending risks and costs and does not have contractual terms which introduce exposure to unrelated risks or volatility. Derecognition of financial liabilities Financial liabilities are derecognised when, and only when, the Company's contractual obligations are discharged, cancelled, or they expire. Equity instruments Equity instruments issued by the Company are recorded at the fair value of proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.
4.
Intangible assets
|
Website |
|
£ |
|
Cost |
|
|
At 1 January 2024 and 31 December 2024 |
91,200 |
|
-------- |
|
Amortisation |
|
|
At 1 January 2024 and 31 December 2024 |
91,200 |
|
-------- |
|
Carrying amount |
|
|
At 31 December 2024 |
– |
|
-------- |
|
At 31 December 2023 |
– |
|
-------- |
|
|
5.
Debtors
|
2024 |
2023 |
|
£ |
£ |
|
Trade debtors |
15,981 |
21,067 |
|
Other debtors |
5,646 |
82 |
|
-------- |
-------- |
|
21,627 |
21,149 |
|
-------- |
-------- |
|
|
|
6.
Creditors:
amounts falling due within one year
|
2024 |
2023 |
|
£ |
£ |
|
Trade creditors |
70,400 |
39,099 |
|
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
1,773,333 |
1,709,556 |
|
Other creditors |
61 |
2,050 |
|
------------ |
------------ |
|
1,843,794 |
1,750,705 |
|
------------ |
------------ |
|
|
|
7.
Summary audit opinion
The auditor's report dated
26 September 2025
was
unqualified
.
The senior statutory auditor was
Stephen Foster
, for and on behalf of
Moore Kingston Smith LLP
.
8.
Controlling party
The parent undertaking of the company is The Conversion Group Ltd, a company incorporated in England and Wales. The address of the registered office of the parent undertaking is Unit 208, Canalot Studios, 222 Kensal Road, London, W10 5BN. The ultimate parent company is Ergo Science Corporation, a company incorporated in the United States of America.